Introduction
============

Magnetic resonance imaging (MRI) is an imaging modality based on the principles of NMR and can be used to directly observe the movement of molecules associated with fluid flow. This provides for an excellent opportunity to noninvasively determine molecular velocities within a confined range, for example due to the formation of plaque in blood vessels.[@b1-mri-6-2013-083]--[@b3-mri-6-2013-083]

Traditionally, MRI generates exquisite images of the soft tissue anatomy of the human body. The principle of MRI is to record the variations of the nuclear magnetization of biological tissues using different kinds of magnetic fields.[@b1-mri-6-2013-083],[@b2-mri-6-2013-083],[@b4-mri-6-2013-083] A static magnetic field *B*~0~ is used to generate a macroscopic nuclear magnetization *M⇀* in the body. By applying an additional pulsed magnetic field $\overset{\rightharpoonup}{B_{1}}$ in the transverse plane, the orientation of *M⇀* can be shifted into this plane as the precession is always around the total magnetic field *B* = *B*~0~ + *B*~1~. To investigate the variations of magnetization *M⇀* in the presence of the field $\overset{\rightharpoonup}{B_{1}}$, it is convenient to use a rotating rather than static frame of reference. The frame is chosen to rotate at the same frequency as $\overset{\rightharpoonup}{B_{1}}$, such that both $\overset{\rightharpoonup}{B_{0}}$ and $\overset{\rightharpoonup}{B_{1}}$ become time-independent. The NMR Bloch flow equations in this frame can be expressed[@b5-mri-6-2013-083]--[@b8-mri-6-2013-083] by the equation:
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with the following parameters: γ-gyromagnetic ratio of fluid spins, *M⇀*~0~-equilibrium magnetization, *T*~1~-spin lattice (longitudinal) relaxation time, *T*~2~-spin-spin (transverse) relaxation time, *V*-variable flow velocity.

In order to calculate the transverse magnetization component *M⇀~y~*, two reasonable initial boundary conditions which may conform to the real time experimental arrangements were chosen. These included the following.

i.  *M*~0~ ≠ *M~x~*, a condition which holds true in general and in particular when there is a small RF limit: *γ* ^2^*B*~1~^2^*T*~1~*T*~2~ \<\< 1. This is typically regarded as a linearity condition in which the frequency response takes on the characteristic Lorentzian form.[@b4-mri-6-2013-083]

ii. For this investigation, we assumed that the resonance condition existed at Larmor frequency:[@b7-mri-6-2013-083]

    $$f_{0} = \gamma B - \omega = 0$$

iii. iii\. Before entering the signal detector coil, fluid particles have magnetization of

     $$M_{x} = 0{\,\,\,}{\,\,\,}{\,\,\,}\text{and \,\,}{\,\,\,}{\,\,\,}M_{y} = 0$$

Under these conditions and for steady flow, we can write
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When the RF *B*~1~(*x*) field is applied, *M~y~* has the largest possible amplitude when RF *B*~1~(*x*) is maximum and *M*~0~ ≈ 0. At this point, when the maximum possible NMR signal amplitude is detected (maximum values of *M~y~* and *B*~1~(*x*) respectively), [equation (1)](#fd1-mri-6-2013-083){ref-type="disp-formula"} becomes:
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In this study, we conducted a detailed analysis of generating functions that may arise from polynomial solutions of [equation (4)](#fd5-mri-6-2013-083){ref-type="disp-formula"} in terms of Legendre polynomials and Boubaker polynomials.[@b9-mri-6-2013-083]--[@b12-mri-6-2013-083] The generating functions of these polynomials can enhance the present understanding of the basic physics required to extract relevant NMR flow information from which various hemodynamic problems can be studied.

Quantitative fluid flow imaging based on the solution of Bloch NMR flow equations in terms of Legendre polynomials and Boubaker polynomials is very important because significant applications of MRI techniques are based on the Bloch NMR equations. Applying appropriate mathematical techniques to solve Bloch NMR flow equations and extract relevant NMR flow parameters to accurately monitor the fluid state is very important for MRI studies.

Mathematical Model
==================

[Equation (4)](#fd5-mri-6-2013-083){ref-type="disp-formula"} was obtained under conditions of when the RF *B*~1~(*x*) field is applied and *M~y~* has a maximum value, *M*~0~ = 0. [Equation (4)](#fd5-mri-6-2013-083){ref-type="disp-formula"} can be written in the form:
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The fluid velocity *V* is dependent on the spatial variable *x*. We may therefore write that:
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where *l* = *l* (*x*) is a parameter in the unit of length and $Cot\frac{x}{l}$ is a cotangent function of $\frac{x}{l}$. [Equation (6)](#fd7-mri-6-2013-083){ref-type="disp-formula"} is based on the condition that:
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Specifically, in this model, we consider a fluid particle confined to a limited range as shown in [Figure 1](#f1-mri-6-2013-083){ref-type="fig"}.

At the point *x*~3~, the fluid velocity *V*(*x*) becomes virtually zero and the blockage stops the blood supply to the area, leading to ischemia (lack of oxygen) and eventually necrosis.

The fluid velocity is completely quantified within the (anatomical) range except at the points (certain discrete values *μ*, an NMR number associated with the NMR transverse magnetization and velocities) where *μ* is odd number because the velocity is infinite at these points (this typically occurs at bifurcations, ie, points *x*~1~ and *x*~2~).

Since the expression of [equation (7)](#fd8-mri-6-2013-083){ref-type="disp-formula"} implies that the fluid velocity is a function of relaxation times, we can assume that *V*~2~ is directly proportional to *T~g~* such that:
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where $\frac{1}{n\,(n + 1)}$ is the constant of proportion (*n* is a positive integer parameter).

From [equations (10)](#fd11-mri-6-2013-083){ref-type="disp-formula"}, we can write:
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If we define $ɛ = Cos\frac{x}{l}$, [equation (13)](#fd14-mri-6-2013-083){ref-type="disp-formula"} becomes
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Dividing [equation (14)](#fd15-mri-6-2013-083){ref-type="disp-formula"} through by $\frac{1}{l^{2}}Sin\frac{x}{l}$, we obtain a Legendre differential equation:
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The solution of [equation (15)](#fd16-mri-6-2013-083){ref-type="disp-formula"} is of the form:[@b13-mri-6-2013-083]--[@b16-mri-6-2013-083]
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where *P~n~* (*ɛ*) and *Q~n~* (*ɛ*) are the Legendre polynomials of the first type and second type, respectively, and *C*~1~ and *C*~2~ are constants. It is worthy of note that *P~n~* (*ɛ*) and *Q~n~* (*ɛ*) are two linearly independent solutions to equation.[@b15-mri-6-2013-083] Hence, *C*~2~ must be equal to zero and *C*~1~ is equal to unity:
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[Equation (17)](#fd18-mri-6-2013-083){ref-type="disp-formula"} can be factorized by its own first term. Setting *m* = *n* − *p*:
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where *B~n~* (*ɛ*) denote the Boubaker polynomials.[@b6-mri-6-2013-083]--[@b9-mri-6-2013-083]
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*B~n~* (*ɛ*) is a polynomial in *ɛ*. The elementary first *n-*indexed solutions are represented in [Figure 3](#f3-mri-6-2013-083){ref-type="fig"}.

Discussion
==========

In [Figure 3](#f3-mri-6-2013-083){ref-type="fig"}, the curves correspond to the vanishing modes of the expression obtained for the transverse magnetization in [Equations (17)](#fd18-mri-6-2013-083){ref-type="disp-formula"} and [(19)](#fd20-mri-6-2013-083){ref-type="disp-formula"}. This feature agrees with the results obtained by Kobayashi et al,[@b16-mri-6-2013-083] Chapman et al,[@b17-mri-6-2013-083] and Donnat et al.[@b18-mri-6-2013-083]

The case *n* = 0 ([Fig. 3](#f3-mri-6-2013-083){ref-type="fig"}) initially corresponds to the reduced equation:
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It is interesting to note that whether the blood flow is laminar or turbulent, a magnetic resonance signal is always available. Specifically, at bifurcations and points just after the build-up of fatty deposits (sections d and e in [Fig. 2](#f2-mri-6-2013-083){ref-type="fig"}) the transverse magnetization *M~y~* is a constant. This indicates that resonant waves can be reconstructed to image the points within the blood vessels where flow is turbulent. [Figures 3](#f3-mri-6-2013-083){ref-type="fig"} and [4](#f4-mri-6-2013-083){ref-type="fig"} suggest that except at points where there is no contribution from velocity, transverse magnetization must be continuous. That is, *M~y~* cannot jump from one value to another. We therefore set the boundary condition for the fluid particle:
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[Equation (7)](#fd8-mri-6-2013-083){ref-type="disp-formula"} shows that an acceptable solution of [equation (6)](#fd7-mri-6-2013-083){ref-type="disp-formula"} according to the assumptions made above can only be obtained if the fluid particle has certain discrete values *μ*, an NMR number associated with the NMR transverse magnetization and velocities. It is very important to note that this parameter is very related to the nature of flow observed within the vessels.

[Figures 3](#f3-mri-6-2013-083){ref-type="fig"} and [4](#f4-mri-6-2013-083){ref-type="fig"}, show the effect of the values of *n* on both Boubaker polynomial *B~n~* and the NMR transverse magnetization *M~y~*. They show the behavior of the NMR signal at several points within the vessel being observed. Notably, [Figure 4](#f4-mri-6-2013-083){ref-type="fig"} demonstrates the importance of the ratio $\frac{x}{l}$. When the value of this term (corresponding to a small distance along the blood vessel as weighted against *l*) is very small ([Fig. 4f](#f4-mri-6-2013-083){ref-type="fig"} ), there is no significant NMR contrast between different points within an in homogeneous voxel. Hence, to observe a significant signal at any location, *l* must be tuned to the corresponding ranges of values; these values can therefore be introduced into k--space encoding the spatial information. We also see that this formulation allows us to sample NMR signals at extremely small values of x, which may be important for better characterization of plague size and morphology.

Studying the Legendre and Boubaker solutions to the Bloch NMR flow equation for the behavior of NMR signals in flowing media is invaluable because it can allow effective monitoring of geometrical and morphological situations in the arteries as well as the possible effect of drugs on cardiovascular related diseases in any tissue. Based on earlier studies,[@b22-mri-6-2013-083]^--24^ *l*(*x*) may be defined in the Cartesian cylindrical and spherical coordinates as shown in [Figure 2](#f2-mri-6-2013-083){ref-type="fig"}, where *l*(*x*) = *h* − *h*~1~. When *n* = 0 and the vessel is not completely blocked, the flow is extremely complex. Values for *n* \> 0 indicate that the size of *h*~1~ is drastically reducing and the velocity *V*(*x*) is becoming more laminar (steady) in oxygenated blood and cerebrospinal fluid (CSF) as shown in [Figure 5](#f5-mri-6-2013-083){ref-type="fig"}. The value of n can be used to indicate the efficacy of any drug useful for reducing plaque size, as shown in [Figure 5](#f5-mri-6-2013-083){ref-type="fig"}.

Similarly, [equation (10)](#fd11-mri-6-2013-083){ref-type="disp-formula"} can be significantly valuable for estimating blood flow of blood vessels with very small cross section area A = *l* ^2^ (*x*), where the value of n may be defined as 0 \< *n* \< 5.

[Figure 6](#f6-mri-6-2013-083){ref-type="fig"} shows the distribution plots for the fluid velocity and the corresponding density plots for different ranges of *l.* These figures show that the study affords us the opportunity of simultaneously adding velocity mapping to MRI of blood flow within the vessels. The points with white open areas are points at which complex or turbulent flow occurs. These points typically coincide with presence of bifurcations and fatty deposits. Additionally, as *l* becomes microscopic and lower, the model becomes more realistic. The points with sharp peaks or the red regions on the density image correspond to highest values of fluid velocity and can be used to determine and also image the presence of fatty deposits.

It may be significant to note that the rotational diffusion coefficient *D~rot~* can be defined from [equation (7)](#fd8-mri-6-2013-083){ref-type="disp-formula"} as,[@b19-mri-6-2013-083],[@b20-mri-6-2013-083] considering that *l* is a fixed length:
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Given that the translational diffusion coefficient is: $D_{trans} = \frac{V^{2}(x)}{T_{g}\tau}$, where τ is the correlation time defined as:[@b19-mri-6-2013-083],[@b20-mri-6-2013-083]
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For the value *n* = 1, *M~y~* (*ɛ*) = *P*~1~(*ɛ*) = *B*~1~(*ɛ*) and the correlation time becomes
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The physical implication for when *n* = 0 can be interpreted as the constant magnetization where the correlation time is observed to be infinitely small.

Finally, the rotational diffusion coefficient as given in [equation (23)](#fd24-mri-6-2013-083){ref-type="disp-formula"} may be written as:[@b19-mri-6-2013-083],[@b20-mri-6-2013-083]
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where *k~B~* is the Boltzman *n* constant, *T* is the absolute temperature of the tumbling blood molecules, and *f~r~* is the rotational friction coefficient. Therefore, the friction coefficient, which provides significant information regarding molecular interactions, is given as:
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Conclusions
===========

We have derived the MRI signal in terms of Legendre and Boubaker polynomials. By solving the Bloch NMR flow equations under some assumptions, we obtained elementary spatial profiles of the transverse magnetization response. The primary advantage of this approach is the potential to exploit spatial-evolution of magnetic response in the presence of a preset rotating field for monitoring the effect of a drug on cardiovascular- related diseases and to estimate blood flow rate in very small blood vessels.

Interestingly, quantification of the velocity is not a direct prediction of [equation (7)](#fd8-mri-6-2013-083){ref-type="disp-formula"}, but it is a consequence of the conditions imposed on the transverse magnetization.

In physical situations in which a fluid particle is confined in space, for example, at *x* = *βl*, $\left( {\text{where} - \frac{\pi}{2} < \beta < + \frac{\pi}{2}} \right)$, most solutions behave in an inappropriate way at the edges of the region of interest. Only for certain precisely determined velocities are satisfactory solutions obtained. The boundary conditions which the transverse magnetization *M~y~* must satisfy cannot be derived. They can be justified in part by the physical interpretation of *M~y~* based on the properties of Boubaker polynomials in [equation (19)](#fd20-mri-6-2013-083){ref-type="disp-formula"}:

i.  *M~y~* must be a well-defined functions of position,

ii. *M~y~* cannot be infinite any where except at the point $x = \frac{\mu\pi l}{2}(\mu = \text{even integer})$,

iii. *M~y~* must be continuous, and not jump abruptly from one value to another.

iv. When *n* = 0, and $x = \frac{\mu\pi l}{2}(\mu = \text{odd integer})$, the transverse magnetization is a constant and the velocity is indeterminate.

v.  The NMR transverse magnetization is directly proportional to Boubaker polynomials.

vi. *M~y~* has the same value as the Boubaker polynomials when *n* = 1.

Detailed study of these NMR flow parameters and properties of the transverse magnetization as described in this study can allow for careful optimization and 3D computer graphics of fluid flow magnetic resonance imaging. A simple illustration of this is given in [Figure 6](#f6-mri-6-2013-083){ref-type="fig"}. The mathematical analysis presented in this study is based on the assumption made in [equation (7)](#fd8-mri-6-2013-083){ref-type="disp-formula"}. This was done with the goal of exploring the spatial evolution of the MRI signal in the presence of a preset rotating field.

The biological, physical, biomedical, and geophysical applications of [equations (17)](#fd18-mri-6-2013-083){ref-type="disp-formula"}, [(19)](#fd20-mri-6-2013-083){ref-type="disp-formula"}, [(23)](#fd24-mri-6-2013-083){ref-type="disp-formula"}, [(25)](#fd26-mri-6-2013-083){ref-type="disp-formula"}, and [(27)](#fd29-mri-6-2013-083){ref-type="disp-formula"} when *n* \> 1 can be used for all NMR/MRI procedures and further application of this study will be presented in separate studies. For an example of the physical properties of a drug designed to reduce the size of *h*~1~ of the fatty deposit in [Figure 2](#f2-mri-6-2013-083){ref-type="fig"} may be revealed by [equations (24](#fd25-mri-6-2013-083){ref-type="disp-formula"}--[27)](#fd29-mri-6-2013-083){ref-type="disp-formula"}.

Notably, the parameter *l* in [equation (7)](#fd8-mri-6-2013-083){ref-type="disp-formula"} is a length used to scale *x*. This parameter may be used for slice selection in spatial encoding in a typical MRI experiment so that *l* can be defined such that:
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where *G* is the applied gradient and τ is the duration of the applied gradient.[@b4-mri-6-2013-083] The area *A*=*l*^2^ (*x*) (which was discussed above) represents the field of view (FOV) for the voxel selected.
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![Illustration of the changes occurring in an ischemic cardiovascular accident and geometrical consideration in coronary artery with atherosclerosis diseases.](mri-6-2013-083f1){#f1-mri-6-2013-083}

![Effect of constriction on the velocity profile in a blood vessel: (ab) Laminar flow velocity *V*, (bc) High velocity *V*~1~, (de) Turbulent, and (eg) Laminar flow. The diameter of the blood vessel is *h*.[@b21-mri-6-2013-083] Reprinted with permission of the Collegium Basilea.](mri-6-2013-083f2){#f2-mri-6-2013-083}

![The n-indexed solutions.](mri-6-2013-083f3){#f3-mri-6-2013-083}

![Plots of transverse magnetization as a function of $\frac{x}{l}$ at *l* = 2.5 *μ*m for *x* between 0 and (**a**) 1.0 m (**b**) 1.0 × 10^−3^ m (**c**) 1.0 × 10^−6^ m (**d**) 1.0 × 10^−9^ m (**e**) 1.0 × 10^−12^ m (**f**) 1.0 × 10^−12^ m.](mri-6-2013-083f4){#f4-mri-6-2013-083}

![The plots of the fluid velocity for molecules of (**a**) cerebrospinal fluid around a "micro-sized" plague (**b**) cerebrospinal fluid around a "nano-sized" plague (**c**) oxygenated blood around a "micro-sized" plague (**d**) oxygenated blood around a "nano-sized" plague.](mri-6-2013-083f5){#f5-mri-6-2013-083}

![The velocity distribution across *l* and *x*, according to [equation (7)](#fd8-mri-6-2013-083){ref-type="disp-formula"} and the corresponding density image for *l* ranging from 0 to (**a**) 9.0 × 10^−3^ m (**b**) 9.0 × 10^−6^ m (**c**) 9.0 × 10^−9^ m (**d**) 9.0 × 10^−12^ m. The relaxations times used are *T*~1~ = 1.03s and *T*~2~ = 0.06s.](mri-6-2013-083f6){#f6-mri-6-2013-083}
